Samantha Schnier focuses on complex commercial litigation, managing all aspects of a case for a wide variety of clients.
Prior to joining Hueston Hennigan, Ms. Schnier was an associate at Davis Polk & Wardwell LLP, where she represented clients in securities litigation, contract disputes, bankruptcy proceedings and internal investigations.
During law school, Ms. Schnier was a clinical intern with the New York Civil Liberties Union and a teaching assistant in the lawyering program. She also served as senior editor for the Journal of Intellectual Property and Entertainment Law.
Ms. Schnier is not yet admitted in California.
Obtained a preliminary injunction on behalf of Amgen, holding that information related to potential price changes submitted to the state pursuant to California Senate Bill 17 is protectable trade secrets and may not be disclosed in response to a California Public Records Act request. This was a highly watched case with huge implications to the pharmaceutical industry.
Representing Sorrento Therapeutics, a biopharmaceutical company that focuses on immune-oncology research, in a suit alleging breach of contract, trade secret misappropriation, tortious interference, breach of fiduciary duties and unfair competition claims against two former employees and the competing companies they founded.